These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 27416144)

  • 21. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of tigemonam, a novel oral monobactam.
    Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of BMS-180680, a new catechol-containing monobactam.
    Fung-Tomc J; Bush K; Minassian B; Kolek B; Flamm R; Gradelski E; Bonner D
    Antimicrob Agents Chemother; 1997 May; 41(5):1010-6. PubMed ID: 9145861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of tigemonam, a novel oral monobactam.
    Clark JM; Olsen SJ; Weinberg DS; Dalvi M; Whitney RR; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):226-9. PubMed ID: 3551830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
    Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y; Yoshida Y; Saitoh K; Nemoto M; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1990 Apr; 43(4):403-10. PubMed ID: 2112533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new monobactams: chemistry and biology.
    Sykes RB; Koster WH; Bonner DP
    J Clin Pharmacol; 1988 Feb; 28(2):113-9. PubMed ID: 3360965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of Ro 17-2301 (AMA-1080) with beta-lactamases.
    Then RL
    Chemotherapy; 1984; 30(6):398-407. PubMed ID: 6335074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
    Verbist L; Glupczynski Y
    Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the usefulness of tests for production of Beta-D-glucuronidase and propylene glycol utilization for the differentiation of enterobacteriaceae rods].
    Kaluzewski S; Tomczuk D
    Med Dosw Mikrobiol; 1995; 47(3-4):155-68. PubMed ID: 8833927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Sekh BR; van Furth R
    Antimicrob Agents Chemother; 1991 Mar; 35(3):417-22. PubMed ID: 2039191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.
    Yourassowsky E; Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1(sup2):49-53. PubMed ID: 27416151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro evaluation of carumonam (Ro 17-2301).
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam.
    García-Rodríguez JA; García-Sánchez JE; Plata A; Trujillano I
    J Antimicrob Chemother; 1986 Mar; 17(3):303-7. PubMed ID: 3754552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal Activity of Tigemonam, Alone and in Combination with Gentamicin.
    Shah PM; Gànger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1(sup2):45-46. PubMed ID: 27416150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.